PIL in Delhi HC to stop launch of Indian company’s stroke drug | Latest News Delhi - Hindustan Times
close_game
close_game

PIL in Delhi HC to stop launch of Indian company’s stroke drug

Aug 24, 2016 07:19 PM IST

Delhi high court on Wednesday sought the Centre and the drug controller general of India’s (DCGI) response on a PIL seeking to stop an Indian pharma company from launching a drug meant for treating stroke patients.

Delhi high court on Wednesday sought the Centre and the drug controller general of India’s (DCGI) response on a PIL seeking to stop an Indian pharma company from launching a drug meant for treating stroke patients.

Delhi high court on Wednesday sought the Centre and the drug controller general of India’s (DCGI) response on a PIL seeking to stop an Indian pharma company from launching a drug meant for treating stroke patients.(Representative image)
Delhi high court on Wednesday sought the Centre and the drug controller general of India’s (DCGI) response on a PIL seeking to stop an Indian pharma company from launching a drug meant for treating stroke patients.(Representative image)

A bench of chief justice G Rohini and justice Sangita Dhingra Sehgal refused to pass an interim order staying the launch of the medicine, but said any such action taken would be subject to further order of the court.

Hindustan Times - your fastest source for breaking news! Read now.

With the direction, the bench listed the matter for hearing on August 31.

The petition has questioned the approval given to Indian drug company Gennova Biopharmaceuticals Ltd with regard to its biosimilar drug of Tenecteplase which is used for treating stroke patients.

The petitioner, Deep Das, has asked how could the biosimilar drug be approved when the innovator drug made by German pharma major Boehringer Ingelheim has not been approved.

He has sought revocation of the recommendations in favour of the biosimilar drug as well as the marketing approval granted to it.

His petition also seeks directions restraining the company from launching the medicine and if launched, a declaration ot the effect that it was done illegally.

According to the petition, DCGI had allowed Gennova to carry out clinical trials of the medicine in February 2009 and December 2013.

Unveiling 'Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, March 19, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On